OR WAIT 15 SECS
© 2021 MJH Life Sciences and Cannabis Science and Technology . All rights reserved.
© 2021 MJH Life Sciences™ , Cannabis Science and Technology . All rights reserved.
December 09, 2020
How will the need for increased testing impact extractors?
December 04, 2020
This article intends to clarify the main goals of GACP and GMP guidelines, identify differences between the two, and also explore why it is important, when operating within the medicinal cannabis sector, that these two guidelines are complied with and their standards achieved.
October 14, 2020
What does FDA oversight mean for cannabis businesses and the industry as a whole?
October 13, 2020
This article discusses the difficulties of reining in the intense energy use of the cannabis industry from the perspective of the most energy efficient state: Massachusetts.
September 24, 2020
Highlights of the challenges facing the cannabis extracts industry and discussion about the need for standardized methods and the role of laboratory accreditation.
An argument for moving away from traditional culture-based methods and towards employing methods with increased specificity and accuracy.
August 05, 2020
The U.S. Food and Drug Administration (FDA) recently released a draft guidance on developing cannabis-based drugs. These guidelines come weeks after the White House announced it had completed reviewing the draft guidance.
June 23, 2020
Here we examine the history of cannabis in the US, the role the USP played in that field, and the new role the USP is taking with cannabis for medical use.
In this article, you will learn about the GxP requirements for laboratories, production facilities, and distribution of cannabis.
May 14, 2020
The industry needs to address energy efficiency, plastic use, and wastewater to build a long-term reputation of accessibility, legitimacy, and sustainability.